![Tae Hwang Sun](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Tae Hwang Sun.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
PeproMene Bio, Inc.
![]() PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Tae Hwang Sun a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Mercy Corps
![]() Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Services to the Health Industry | Director/Board Member | |
The University of Chicago | College/University | Undergraduate Degree | |
NKMAX CO., LTD. | Biotechnology | Chief Tech/Sci/R&D Officer | |
George Washington University School of Medicine & Health | College/University | Doctorate Degree | |
NKGen Biotech, Inc.
![]() NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Biotechnology | Chief Executive Officer | |
Fuse Biotherapeutics, Inc.
![]() Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Biotechnology | Founder | |
Gideons Promise, Inc. | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 7 |
Corea del Sur | 2 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Health Services | 2 |
Operativa
Director/Board Member | 8 |
Chief Executive Officer | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Chairman | 2 |
Founder | 2 |
Las relaciones más conectadas
Insiders | |
---|---|
Paul Y. Song | 9 |
Bryan Hong | 1 |
Ki Park Yung | 1 |
Sup Chin Hwa | 1 |
- Bolsa de valores
- Insiders
- Tae Hwang Sun
- Conexiones Empresas